Literature DB >> 21498525

In vivo imaging of intraprostatic-specific gene transcription by PET.

Frédéric Pouliot1, Breanne D W Karanikolas, Mai Johnson, Makoto Sato, Saul J Priceman, David Stout, Joanne Sohn, Nagichettiar Satyamurthy, Jean B deKernion, Lily Wu.   

Abstract

UNLABELLED: Better intraprostatic cancer imaging techniques are needed to guide clinicians in prostate cancer treatment decisions. Because many genes are specifically overexpressed in cancer cells, one strategy to improve prostate cancer detection is to image intraprostatic cancer-specific transcriptional activity. Because of the obstacles of weak cancer- or tissue-specific promoter activity and bladder clearance of many PET tracers, intraprostatic PET of gene transcriptional activity has not been previously reported.
METHODS: The two-step transcriptional amplification (TSTA) system that amplifies the prostate-specific antigen promoter activity was used for PET imaging of the reporter gene herpes simplex virus type-1 sr39 thymidine kinase (HSV1-sr39tk). The TSTA-sr39tk system was injected directly into prostates or prostatic tumors as a replication-incompetent adenovirus (AdTSTA-sr39tk) and imaged using PET.
RESULTS: AdTSTA-sr39tk was able to image prostate-specific antigen promoter transcriptional activity by 9-(4-(18)F-fluoro-3-[hydroxymethyl]butyl)guanine PET, in both mouse and canine prostates in vivo. Ex vivo small-animal PET images, scintigraphic counts, and sr39tk expression analysis confirmed the specificity of the observed signal.
CONCLUSION: Here, by combining the TSTA-amplified signal with a protocol for tracer administration, we show that in vivo PET detection of transcriptional activity is possible in both mouse and immunocompetent canine prostates. These results suggest that imaging applications using transcription-based tumor-specific promoters should be pursued to better visualize cancer foci that escape detection by conventional biopsies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21498525      PMCID: PMC3173510          DOI: 10.2967/jnumed.110.084582

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  36 in total

1.  Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro.

Authors:  J Winer; C K Jung; I Shackel; P M Williams
Journal:  Anal Biochem       Date:  1999-05-15       Impact factor: 3.365

2.  Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.

Authors:  David M Schuster; John R Votaw; Peter T Nieh; Weiping Yu; Jonathon A Nye; Viraj Master; F DuBois Bowman; Muta M Issa; Mark M Goodman
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

Review 3.  Advances in preclinical investigation of prostate cancer gene therapy.

Authors:  Marxa L Figueiredo; Chinghai Kao; Lily Wu
Journal:  Mol Ther       Date:  2007-04-24       Impact factor: 11.454

4.  Micro-PET/CT monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft: the advantage of a cell-specific transcriptional targeting approach.

Authors:  Mai Johnson; Makoto Sato; Jeremy Burton; Sanjiv S Gambhir; Michael Carey; Lily Wu
Journal:  Mol Imaging       Date:  2005 Oct-Dec       Impact factor: 4.488

5.  Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.

Authors:  K A Klein; R E Reiter; J Redula; H Moradi; X L Zhu; A R Brothman; D J Lamb; M Marcelli; A Belldegrun; O N Witte; C L Sawyers
Journal:  Nat Med       Date:  1997-04       Impact factor: 53.440

6.  Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells.

Authors:  W Hamel; L Magnelli; V P Chiarugi; M A Israel
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

7.  Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.

Authors:  Anna Bill-Axelson; Lars Holmberg; Frej Filén; Mirja Ruutu; Hans Garmo; Christer Busch; Stig Nordling; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Juni Palmgren; Hans-Olov Adami; Jan-Erik Johansson
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

8.  Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era.

Authors:  Jean O Ung; Jerome P Richie; Ming-Hui Chen; Andrew A Renshaw; Anthony V D'Amico
Journal:  Urology       Date:  2002-09       Impact factor: 2.649

Review 9.  Non-invasive molecular imaging of prostate cancer lymph node metastasis.

Authors:  Frédéric Pouliot; Mai Johnson; Lily Wu
Journal:  Trends Mol Med       Date:  2009-05-29       Impact factor: 11.951

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

View more
  7 in total

Review 1.  Molecular imaging of prostate cancer: PET radiotracers.

Authors:  Hossein Jadvar
Journal:  AJR Am J Roentgenol       Date:  2012-08       Impact factor: 3.959

Review 2.  Cancer imaging: Gene transcription-based imaging and therapeutic systems.

Authors:  Hyo-eun C Bhang; Martin G Pomper
Journal:  Int J Biochem Cell Biol       Date:  2012-02-10       Impact factor: 5.085

3.  Homologous recombination-based adenovirus vector system for tumor cell-specific gene delivery.

Authors:  Qin Lu; Xun Ye; Fang Liu; Yi Zhao; Jie Qin; Min Liang; Chao Fang; Hong-Zhuan Chen
Journal:  Cancer Biol Ther       Date:  2013-06-12       Impact factor: 4.742

4.  A molecular imaging system based on both transcriptional and genomic amplification to detect prostate cancer cells in vivo.

Authors:  Frédéric Pouliot; Makoto Sato; Ziyue Karen Jiang; Steve Huyn; Breanne Dw Karanikolas; Lily Wu
Journal:  Mol Ther       Date:  2012-12-18       Impact factor: 11.454

Review 5.  Molecular Imaging of Prostate Cancer.

Authors:  Andreas G Wibmer; Irene A Burger; Evis Sala; Hedvig Hricak; Wolfgang A Weber; Hebert Alberto Vargas
Journal:  Radiographics       Date:  2015-11-20       Impact factor: 5.333

Review 6.  A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy.

Authors:  Susanna C Concilio; Stephen J Russell; Kah-Whye Peng
Journal:  Mol Ther Oncolytics       Date:  2021-03-10       Impact factor: 7.200

7.  A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.

Authors:  Bertrand Neveu; Pallavi Jain; Bernard Têtu; Lily Wu; Yves Fradet; Frédéric Pouliot
Journal:  Oncotarget       Date:  2016-01-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.